Essential Planning LLC. Makes New $934,000 Investment in Henry Schein, Inc. (NASDAQ:HSIC)

Essential Planning LLC. bought a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 13,000 shares of the company's stock, valued at approximately $934,000.

Several other hedge funds also recently bought and sold shares of HSIC. Versant Capital Management Inc raised its position in Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after purchasing an additional 335 shares in the last quarter. Venturi Wealth Management LLC lifted its holdings in Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after buying an additional 569 shares during the period. Quent Capital LLC boosted its position in Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after acquiring an additional 323 shares in the last quarter. Smartleaf Asset Management LLC grew its holdings in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after acquiring an additional 143 shares during the period. Finally, City State Bank purchased a new position in shares of Henry Schein in the 4th quarter valued at approximately $55,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Price Performance

Shares of NASDAQ:HSIC traded up $1.22 during midday trading on Monday, reaching $71.80. 2,009,568 shares of the company were exchanged, compared to its average volume of 1,505,096. The stock has a market cap of $8.92 billion, a PE ratio of 29.55, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The business's fifty day moving average is $74.84 and its two-hundred day moving average is $72.62. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Remove Ads

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period last year, the firm posted $0.66 earnings per share. The company's revenue for the quarter was up 5.8% compared to the same quarter last year. As a group, analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analysts Forecast Growth

HSIC has been the subject of several research reports. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price target for the company. Barrington Research reaffirmed an "outperform" rating and set a $90.00 price objective on shares of Henry Schein in a research report on Wednesday, February 26th. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and boosted their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Jefferies Financial Group lifted their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Finally, UBS Group reduced their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research note on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Henry Schein currently has an average rating of "Moderate Buy" and an average target price of $81.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.